托彻普结构式
|
常用名 | 托彻普 | 英文名 | Torcetrapib |
---|---|---|---|---|
CAS号 | 262352-17-0 | 分子量 | 600.47 | |
密度 | 1.4±0.1 g/cm3 | 沸点 | 504.8±50.0 °C at 760 mmHg | |
分子式 | C26H25F9N2O4 | 熔点 | 54-58ºC | |
MSDS | 中文版 美版 | 闪点 | 259.1±30.1 °C | |
符号 |
GHS07 |
信号词 | Warning |
托彻普用途Torcetrapib(CP-529414)是CETP高效抑制剂,IC50值为37nM。 |
中文名 | 托彻普 |
---|---|
英文名 | torcetrapib |
中文别名 | (2R,4S)-4-[(3,5-双三氟甲基苄基)甲氧基甲酰氨基]-2-乙基-6-三氟甲基-3,4-二氢-2H-喹啉-1-羧酸乙酯 |
英文别名 | 更多 |
描述 | Torcetrapib(CP-529414)是CETP高效抑制剂,IC50值为37nM。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.4±0.1 g/cm3 |
---|---|
沸点 | 504.8±50.0 °C at 760 mmHg |
熔点 | 54-58ºC |
分子式 | C26H25F9N2O4 |
分子量 | 600.47 |
闪点 | 259.1±30.1 °C |
PSA | 59.08000 |
LogP | 7.76 |
外观性状 | 液体 |
蒸汽压 | 0.0±1.3 mmHg at 25°C |
折射率 | 1.512 |
储存条件 | Store at RT |
Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through Nox-dependent processes.
J. Pharmacol. Exp. Ther. 353(1) , 27-34, (2015) Hyperaldosteronism and hypertension were unexpected side effects observed in trials of torcetrapib, a cholesteryl ester-transfer protein (CETP) inhibitor that increases high-density lipoprotein. Given... |
|
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients.
BMJ 349 , g4379, (2014) To investigate the effects on cardiovascular outcomes of drug interventions that increase high density lipoprotein levels.Meta-analysis.Therapeutic benefit of niacin, fibrates, and cholesteryl ester t... |
|
Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.
Xenobiotica 44(7) , 591-605, (2014) 1. Elaborate studies of cholesteryl ester transfer protein (CETP) polymorphisms and genetic deficiency in humans suggest direct links between CETP, high-density lipoprotein cholesterol (HDL-c) levels ... |
1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl](methoxycarbonyl)amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, ethyl ester, (2R,4S)- |
Torcetrapib |
Ethyl (2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-1(2H)-quinolinecarboxylate |
MFCD08063631 |
Ethyl (2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate |
ethyl (2R,4S)-4-[[3,5-bis(trifluoromethyl)phenyl]methyl-methoxycarbonylamino]-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinoline-1-carboxylate |